BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20629504)

  • 1. Screening Europe 2010: an update about the latest technologies and applications in high-throughput screening.
    Merten CA
    Expert Rev Mol Diagn; 2010 Jul; 10(5):559-63. PubMed ID: 20629504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA
    Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards the miniaturization of GPCR-based live-cell screening assays.
    Martins SA; Trabuco JR; Monteiro GA; Chu V; Conde JP; Prazeres DM
    Trends Biotechnol; 2012 Nov; 30(11):566-74. PubMed ID: 22921755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward high-throughput drug screening on a chip-based parallel affinity separation platform.
    Ohlson S; Duong-Thi MD; Bergström M; Fex T; Hansson L; Pedersen L; Guazotti S; Isaksson R
    J Sep Sci; 2010 Sep; 33(17-18):2575-81. PubMed ID: 20730836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High content screening: seeing is believing.
    Zanella F; Lorens JB; Link W
    Trends Biotechnol; 2010 May; 28(5):237-45. PubMed ID: 20346526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesis-driven screening.
    Schopfer U; Engeloch C; Höhn F; Mees H; Leeds J; Glickman F; Scheel G; Ferrand S; Fekkes P; Pfeifer M
    Methods Mol Biol; 2009; 575():297-316. PubMed ID: 19727621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicellular tumor spheroids: an underestimated tool is catching up again.
    Hirschhaeuser F; Menne H; Dittfeld C; West J; Mueller-Klieser W; Kunz-Schughart LA
    J Biotechnol; 2010 Jul; 148(1):3-15. PubMed ID: 20097238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A robust high-throughput sandwich cell-based drug screening platform.
    Zhang S; Tong W; Zheng B; Susanto TA; Xia L; Zhang C; Ananthanarayanan A; Tuo X; Sakban RB; Jia R; Iliescu C; Chai KH; McMillian M; Shen S; Leo H; Yu H
    Biomaterials; 2011 Feb; 32(4):1229-41. PubMed ID: 20971505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of microarrayed compound screening.
    Hoever M; Zbinden P
    Drug Discov Today; 2004 Apr; 9(8):358-65. PubMed ID: 15081963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening: update on practices and success.
    Fox S; Farr-Jones S; Sopchak L; Boggs A; Nicely HW; Khoury R; Biros M
    J Biomol Screen; 2006 Oct; 11(7):864-9. PubMed ID: 16973922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
    Shou WZ; Zhang J
    Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century.
    Johnstone AF; Gross GW; Weiss DG; Schroeder OH; Gramowski A; Shafer TJ
    Neurotoxicology; 2010 Aug; 31(4):331-50. PubMed ID: 20399226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-optical screening platforms: the next wave in label-free screening?
    Cooper MA
    Drug Discov Today; 2006 Dec; 11(23-24):1068-74. PubMed ID: 17129825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro methods to assess drug precipitation.
    Dai WG
    Int J Pharm; 2010 Jun; 393(1-2):1-16. PubMed ID: 20347943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image-based chemical screening.
    Carpenter AE
    Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.